مجله علمی - پژوهشی فقه پزشکی

References

*** Holly Quran

Available from: Https://aa.com.tr/fa/2300331

FAO.ORG. The State of the World’s Land and Water Resources for Food & Agriculture(solaw). Np. 2011. 8. [In English]

Maslow, A. Motiviation and Personality. Translated by: Ahmad rezvani. 1954(1332). 4:312. [In Persian]

Scholtz, D. Theories of Personality. translated by: yousef karim, et al. Tehran: Arasbaran.2005(1383). 5(11):356-358. [In Persian]

Maslow, A. Motiviation and Personality. Harperand Row. 59-77. [In English]

Kātūzīyān, N. Qawāʿid ʿUmūmī Qarārdādhā. Tehran: Bihnashr. 2013(1391).19. [In Persian]

Iran Constitution, Article4.

Wolter F, Puchta H. “Knoking Out Consumer Concerns and Regulator S Rule: Efficient Use of CRISPR/CAS Ribonucleoprotein Complexes for Genome Editingin Cereals”. Journal of Genome Biology. 2017. (18):43. [In English]

Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Hovarth P, et al. “Evolution and classification of the CRISPR-CAS system”. Nature. 2011. 9:467-477. [In English]

Marraffini LA & Sontheimer EJ. “Self Versus Non-Self Discrimination During CRISPR RNA-Directed Immunity”. Nature. 2010. 463(7280):568-571. [In English]

James, C. Global Status of Commercialized Biotech, GM, Crops, IsAAA Brief. IsAA: Ithaca NY. 2013. 2,265-266. [In English]

Yoshimi K, Mashimo T. "Genome Editing Technology and Applications with the Type ICRISPR System”. Journal of Gene and Genome Editing. 2022. 34(100013): 1. [In English]

Basudev, Gh. “a Birds‑Eye‑View on CRISPR‑Cas System in Agriculture”. The Nucleus. 2023. 89-94. [In English]

Wenestorm, A. Risk Assessment of Genetically Modified Undomesticated Plants. Wallingford: CABI. 2004. 297-307. [In English]

Luṭfīwand, M. Bīutiknuluzhī wa Muhandisī Zhinitīk. Tabriz: Āltīn. 2015(1393).15. [In Persian]

Shew A, Danforth D, Nalley l, Tisobe f, Dixon b. "Innoviations in Agricultur Biotech:Consumer Acceptance of Topical RNA in Rice Production”. Journal of Food control. 2017. 81:189-195. [In English]

Atharinia, M. “Transgenic products and newmethods to identify them”. Journal of Biosafety. 2020(1399). 12(2):77-94. [In Persian]

Raza H, Ashar Abdullah M, Khaliq S, Haidar Sajjad M, Elahi M, Raffay Khan M. “Role of CRISPR in Crop Improvement”. Asian Journal of Research in agriculture and Forestry.10:12-19. [In English]

Ishino Y, Shingawa H, Makino k, Amemura M, Nakata A. “Nucleotide Sequence of the Iap Gene,Responsible for Alkaline Phosphatase Isozyme Conversion in Escherichia coli, and Identification of the Gene Product”. Journal Of Bacteriology.1987. 169(12):5429-5433. [In English]

Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, et al. “CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes”. Science. 2007. 315:1709-1712. [In English]

Horvath P, Barrangou R, Fremaux c, Boyaval P & Romero D. Use of a Cas Gene in Combination with CRISPR Repeats for Modualating Resistance in a Cell. US Patient Application. 2006. No 033167. [In English]

Isaacson, W. The code Breaker: Jennifer Dudna, Gene Editing & the Future on the Human Race. New York: Simon & Schster. 2021. 1. [In English]

Brouns SJ, et al. “CRISPR Rnas Guide Antiviral Defense in Prokaryotes”. Science. 2008. 321(5891):960-964. [In English]

Marriffani LA & Sontehimer EJ. “CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci Targeting DNA”. Sience. 322(5909):1843-1845. [In English]

lockyer EJ. “The Potential of CRISPR-CAS9 for Treatinggenetic Disorders: Bioscience Horizon”. The International Journal of Student Research. 2016. 9(hzw012):1-7. [In English]

Cai l, Fisher A, Huang H & Xie Z. "CRISR Mediated Genome Editing and Human Disease”. Journal of Gene and Diseases. 2016. 244-251. [In English]

Tebas p, Stein D & Tang w. “Gene Editing of CCR5 In Autologuscd4 T Cell of Persons Infected with HIV”. Journal of Medicine. 2014. 902. [In English]

Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. “Genome Scale CRISPR –CAS9 Knockout Screening in Human Cell”. Science. 2014. 343: 84-87. [In English]

Wang Y, Cheng X, Shan Q, Zhang Y, Liu J, Gao C, et al. “Simultaneous Editing of Three Homoeoalleles in Hexaploid Bread Wheat Confers Heritable Resistance to Powdery mildew”. Nat Biotechnol. 2014. 32:947-951. [In English]

Bortesi L & Ficher R. “The CRISPR/CAS9 System for Plant Genome Editing and Beyond Elsevier”. Biotechnology Advances. 2015. 33:41-52. [In English]

Ahmar S, Gill RA, Jung H, Faheem A, Qasim M, Mubeen M, Zhou, W. “Conventional and Molecular Techniques from Simple Breeding to Speed Breeding in Crop Plants: Recent Advances and Future”. International Journal of Molecular sciences. Nd.2020. 21: Issue No.7. [In English]

Cho KS, Kim JM & Kim JS. Targeted Genom Engineering in Human Cell with the CAS9 RNA-Guided Endonuclease. Nature Biotechnology. 2013. 31:230-232. [In English]

Miao J, Guo D & Qu L. “Targeted Mutagenesis in Rice Using CRISPR-CAS System”. Cell research. 2013. 23:1233-1236. [In English]

Ainley WM, Sastry-dent L, Welter ME, Murray MG, Zeitler B, Aroma R, et al. “Trait stacking via targeted genome editing”. Journal of Plant Biotechnology. 11:1126-1134. [In English]

Kafle, S. “CRISPR/cas9: a New Paradigm for Crop Improvement Revolutionizing Agriculture”. Journal of Agriculture and Food Research. 2023. 11(100484):1-7. [In English]

Zaidi S.S.E.A, Mukhtar M.S, Mansoor S. “Genome Editing: Targeting Susceptibility Genes for Plant Disease Resistance”. Trends Biotechnol. 2018. 36: 898–906. [In English]

Jiaojiao H, et al. “CRISPR Editing in Biological and Biomedical Investigation”. Journal of Cellular Physiology. 2017. 118: issue No. 12:4152. [In English]

Khan sherish, Shahid mahmood. muhammad, Ahmad. aftab. “CRISPR /CAS9: the jedi against the dark empire of disease”. Journal of Biomedical Sience. 2018. 25(29): 1-18. [In English]

Lin P, Shen G, Guo K, Qin S, Pu Q, Wang Z, et al. “Type III CRISPR-based RNA editing for programmable control of SARS-CoV2 and human coronaviruses”. Nucleic Acids Res. 2022. 8(50):1. [In English]

Sridhara S, Goswami HN, Whyms C, Dennis JH & Li H. “Virus Detection Via Pro- Grammable Type III-A CRISPR-Cas Systems”. Nat Commun. 2021. 12:5653, [In English]

Xu Y & Li Z. “CRISPR-Cas Systems: Overview, Innovations and Applications in Humandisease Research and Gene Therapy”. Computational and Structural Biotechnology Journal. 2020. 18: 2401–2415. [In English]

Gantz VM & Bier E. “The Mutagenic Chain Reaction:a Method for Coverting heterozygous to Homozygous Mutation”. Science. 2015. 348(6233):442-444. [In English]

Zhang Xiao-hui, Y Tee Louis,Wang Xiao-Gang, Huang Q, Yang Shi-hua. “Off Target Effect in CRISPR/CAS9-Mediated Genome Engineering”. Official Journal of the American society of gene and cell therapy. 2015. 4:264. [In English]

Ran F, Hsu p, Right J, et al. “Genome engineering using the CRISPR/CAS9 system protocol”. Nature protocol. 2013. 18(11):2281-2308. [In English]

Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJJ, van der Oost J, et al. “Structures of the RNA-guided Surveillance Complex from a Bacterial Im- Mune System”. Nature. 2011. 477:486-489. [In English]

Xiao Y, Luo M, Hayes RP, Kim J, Ng S, Ding F, et al. “Structure basis for direc- tional R-loop formation and substrate handover mechanisms in type I CRISPR-Cas system”. Npn. 2017. 170:48-60. [In English]

Anşārī, M. al-Musūʿat al- Fiqhīyyat. Qum: Sharīʿat. 1999(1420). 3:330. [in Arabic]

Muḥaqqiq Dāmād, SM. Qawāʿid Fiqh (Jazā). Tehran: Nashr ʿUlūm Islāmī. 2021(1399).4:27. [In Persian]

Ḥurr ʿĀmulī, M. Wasāʾil al-Shīʿat. Qum: Āl al-Bayt. 1993(1414). 18:127-128. [In Arabic]

Walāyī, ʿī. Farhang Tashrīḥī Işṭilāḥāt Uşūl. 6th Ed. Tehran: Niy. 2008(1387). 175-176. [In Persian]

Şadr, MB. Uşūl al-Fiqh. Np: Nashr Islāmī. Nd. 63-64. [In Persian]

Şadr, MB. al-Maʿālim al-Jadīdat lil-Uşūl. Qum: Şadr. 2000(1379).124-125. [In Arabic]

Mishkīnī, ʿA. Işṭilāḥāt al-Uşūl. Qum: Yāsir. 1969(1388). 121. [In Arabic]

Ḥakīm M. al- Uşūl al- ʿĀmmat Lil-Fiqh al-Muqārin. Tehran: al-Majmaʿ al- ʿĀlamī Lil-Taqrīb Bayn al-Madhāhib al-Islāmīyyat. 2015(1394). 78. [In Arabic]

Hāshimī Shāhrūdī, SM. Farhang Fiqh Fārsī. Np: Dāʾirat al-Maʿārif Fiqh al-Islāmī. 1:507. [In Persian]

[50]; 15:257. [In Arabic]

Majīd, GH. Nahj al-Faşāḥat. Qum: Anşārīyān. 2000(1379). 1:55. [In Persian]

[50]; 19:34 [In Arabic]

Irandoust Z, Marhemati Z & Dehnavi M. “An Overview of the CRISPR Tool for Editing Gengan”. Iranian Journal of Biology. 2021(1399). 5(10): 86 &96 [In Persian]

Valian Broujeni S & Mohammadi Farsani F. “CRISPR CAS9 and Its Application Genetically Diseases”. Journal of Laboratory and Diagnosis. 2017(1395). 37: 7-13. [In Persian]

Redman M, et al. What is CRISPR /cas9. parct Ed Arch Dis Child Educ. Np. Npn. 2016. 213-215:101. [In English]

DH su, P, S.lander E & Zhang F. Development and Applications of CRISPR-CAS9 for Genome Engineering. Np. Npn. 2014. 157:1262-1278. [In English]

Zarei B, Zeynivand A & Mohammadi K. “Nafye Sabil in Islamic Thought and Islamic Republic of Iran`s Foreign Policy”. Journal of Contemporary Research on Islamic revolution. 2016(1396). 36:169. [In Persian]

Ṭabāṭabāyī, SM. Tafsīr al-Mīzān. Tranlated by: M.bagher mousavi hamedani. Qum: al-Nashr al-Islāmī. 1995(1374). 10: 461-462. [In Persian]

Ghanbarpour B & Naghibi Sa. “Studying the Jurisprudential decree of Genome Editing for Therapeuticpurposes”. Medical Figh Journal. 2022(1400). 14(44):1-14. [In Persian]

[49]; 171. [In Persian]

Sīstānī, ʿA. Qāʾidih Lā Ḍirār. 2nd Ed. Tehran: Khursandī. 2017(1395). 291-292. [In Persian]

Kātūzīyān, N. Waqāyiʿ Ḥuqūqī: Masʾūlīyyat Madanī. 7th Ed. Tehran: Ganj Dānish. 2021(1399). 38. [In Persian]

Alidoost, A. “The extent of sanctity of changing God's creation from the perspective of the Quran”. Journal of Quran, jurisprudence and Islamic law. 2015(1393). 3:7-12. [In Persian]

Ibn Manẓūr, M. Lisān al- ʿArab. Qum: Adab al- Ḥuzat. 1885 (1405). 4:484. [In Arabic]

Juharī, I. Şiḥāḥ al-Lughat. Np: Dār al-Kitāb al-ʿArabī. 1993(1413). 2:719. [In Arabic]

Fīrūz Ābādī, M. al-Qāmūs al-Muḥīṭ. Ciaro: Bulāgh. 1872(1289). 77. [In Arabic]

Fayyūmī, A. al-Mişbāḥ al-Munīr. Beirut: Dār al-ʿIlm. 1993(1414). 2:360. [In Arabic]

Rāghib Işfahānī, Ḥ. Mufradāt Alfāẓ al-Qurʾān. Beirut: Dār al-Qalam. 1992(1412). 503. [In Arabic].

Ḥakīm M. al- Uşūl al- ʿĀmmat Lil-Fiqh al-Muqārin. Beirut: Andalusia. 1936(1354).19. [In Arabic]

Bujnūrdī, SM. Qawāʿid Fiqhīyyat. 2nd Ed. Qum: Ismāʿīlīyān. 1993(1413). 1:278. [In Arabic]

Available from:

https://mnoormofidi.com/399/10/07/%D8%AC%D9%84%D8%B3%D9%87-%D9%BE%D9%86%D8%AC% D8%A7%D9%87-%D9%88-%DA%86%D9%87%D8% A7%D8%B1%D9%85-%D9%82%D9%84%D9%85% D8%B1%D9%88-%D8%B6%D8%B1%D8%B1-%D8 %AC%D9%87%D8%AA-%D8%AF%D9%88%D9 %85-%D8%AD%D8%AF

Najafī, M. Jawāhir al-Kalām. 7th Ed. Beirut: Dār Iḥyāʾ al-Turāth al- ʿArabī. 1983(1403). 16: 159. [In Arabic]

[68]; 288 &289. [In Persian]

Available from:

https://mnoormofidi.com/1399/10/07/%d8%ac%d9% 84%d8%b3%d9%87-%d9%be%d9%86%d8%ac%d8% a7%d9%87-%d9%88-%d9%be%d9%86%d8%ac%d9% 85-%d9%82%d9%84%d9%85%d8%b1%d9%88-%d8% b6%d8%b1%d8%b1-%d8%ac%d9%87%d8%aa-%d8% af%d9%88%d9%85-%d8%ad%d8% af-%d9%88/